Overall rank by patents
#28,817
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 13 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
Genesense holds 9 US patents across 13 technology areas, rank #28,817 of 50,000 tracked assignees.
Genesense Technology Inc. has been granted 9 US utility patents between 2021 and 2023, placing Genesense Technology Inc. at rank #28,817 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.8 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Genesense Technology Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Genesense sits between Gammatile Llc (9 patents, rank #28,813) and Gfbiochemicals IP Assets B.v. (9 patents, rank #28,821) - the closest US assignees by grant volume. The composite Innovation Score of 34.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Genesense Technology Inc.'s 19.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Genesense Technology Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GAMMATILE LLC
9 patents
GDF SUEZ
9 patents
GEA REFRIGERATION GERMANY GMBH
9 patents
GEBO PACKAGING SOLUTIONS FRANCE SAS
9 patents
GENTHERM AUTOMOTIVE SYSTEMS (CHINA) LTD.
9 patents
GEOMAGICAL LABS, INC.
9 patents
GEORGE TFE SCP
9 patents
GFBIOCHEMICALS IP ASSETS B.V.
9 patents
GENESENSE TECHNOLOGY INC.
9 patents
What this shows Genesense holds 9 patents at rank #28,817, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,817 in granted patent volume.
Other assignees with the most granted patents in Genesense's primary technology class.
Genesense's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 52% higher than 48% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 7 | 77.8% |
| 2023 | 2 | 22.2% |
Top 13 of 13 technology areas
Overall rank by patents
#28,817
Across all tracked assignees
34.5 out of 100
How to use this portfolio
Genesense's 9 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.